Prenetics Global Ltd

PRE Biotech & pharma

Develops COVID-19 tests for healthcare providers.

Dec 2024Revenue $30.6M/yrExpenses $78.8M/yr
No trendCash runway ≈ 1.7 years from Dec 2024
Figures by year

When will Prenetics Global be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2024, revenue was $30.6M and expenses $78.8M.

Fiscal year toRevenueExpensesOperating profit
Dec 2024$30.6M$78.8M−$48.1M
Dec 2023$21.7M$73.6M−$51.9M
Dec 2022$13.2M$79.2M−$66.0M
Dec 2021−$3.20M$53.5M−$56.7M
Dec 2020$65.2M$66.2M−$995K